Business
Arius to begin trading on the Toronto Stock Exchange
Arius to begin trading on the Toronto Stock Exchange.
About this update from Affinity Metals Corp
[{"type":"text","content":"\n\n\n\n\nTORONTO, July 21 /CNW/ - ARIUS Research Inc. (\"ARIUS\") (TSX-V: ARI),\ntoday announced that its common shares will begin trading on the Toronto Stock\nExchange (\"TSX\") at the market open on Monday, July 24, 2006, under the symbol\n\"ARI\". In conjunction with its move to the TSX, ARIUS' common shares will be\nde-listed from and cease trading on the TSX Venture Exchange on market close\non July 21, 2006.\n\nAbout ARIUS Research\n\nARIUS Research Inc. is a biotechnology company dedicated to personalizing\ncancer therapy through the discovery and development of novel anticancer\nmonoclonal antibodies (MAbs). Established in 1999, ARIUS has built a\nproprietary technology platform, FunctionFIRST(TM), that rapidly identifies\npowerful MAbs targeting a variety of cancer indications. This antibody\ngeneration engine has enabled ARIUS to assemble a growing pipeline, which is\nused for commercial collaborations and in-house development. ARIUS has ongoing\npartnerships with key biotechnology and drug development companies. The\ncompany is listed on the TSX Venture Exchange under the symbol \"ARI\".\n\nThe TSX Venture Exchange has not reviewed and does not accept\nresponsibility for the adequacy or accuracy of this statement.\n\nForward-Looking Statement\n\nCertain statements in this news release constitute \"forward-looking\nstatements\" within the meaning of the Private Securities Litigation Reform Act\nof 1995, which involve known and unknown risks, uncertainties and other\nfactors that may cause our actual results to be materially different from any\nfuture results, performance or achievements expressed or implied by such\nstatements. Forward-looking statements in this release include, but are not\nlimited to, ARIUS successfully advancing its new product programs as well as\nlicensing opportunities. These statements are only predictions and actual\nevents or results may differ materially. Factors that could cause such actual\nevents or results expressed or implied by such forward-looking statements to\ndiffer materially from any future results expressed or implied by such\nstatements include, but are not limited to: early stage of development;\ntechnology and product development; dependence on and management of current\nand future corporate collaborations; future capital needs; uncertainty of\nadditional funding; no assuran...